Lack of association of VEGF (-2578 C → A) and ANG 2 (-35 G → C) gene polymorphisms with the progression of retinopathy of prematurity

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 6, 2009, Pages 859-860

  Shastry, Barkur S ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANGIOPOIETIN 2; CYTOSINE; GENOMIC DNA; GUANINE; MESSENGER RNA; VASCULOTROPIN;

BIRTH WEIGHT; BLINDNESS; BLOOD SAMPLING; DISEASE COURSE; DNA ISOLATION; ENVIRONMENTAL FACTOR; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GESTATIONAL AGE; HEREDITY; HUMAN; LETTER; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANGIOPOIETIN-2; BIRTH WEIGHT; DISEASE PROGRESSION; GENE FREQUENCY; GENOTYPE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67349221743     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0988-z     Document Type: Letter

References (10)

1. Shastry BS, Pendergast D, Hartzer MK, Liu X, Trese MT (1997) Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 115:651-656
2. Haider MZ, Devarajan LV, Al-Essa M, Kumar HA (2002) A C597A polymorphism in the Norrie disease gene is associated with advance retinopathy prematurity in Kuwaiti infants. J Biomed 9:365-370
3. Hutcheson KA, Paluru PC, Bernstein SL, Koh J, Rappaport EF, Leach RA, Young TL (2005) Norrie disease gene sequence variants in an ethically diverse population with retinopathy of prematurity. Mol Vis 11:501-508
4. Bizzarro MJ, Hussain N, Jonsson B, Feng R, Ment LR, Gruen JR, Zhang H, Bhandari V (2006) Genetic susceptibility to retinopathy of prematurity. Pediatrics 118:1858-1863. doi: 10.1542/peds.2006-1088
5. Alon T, Hemo I, Itin A, Peer J, Stone J, Kesht E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications to retinopathy of prematurity. Nat Med 1:1024-1028. doi: 10.1038/nm1095-1024
6. Sonmez K, Drenser KA, Capone A, Trese MT (2008) Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmol 115:1065-1070. doi: 10.1016/j.ophtha.2007.08.050
7. Cook RWI, Drury JA, Mountford R, Clark D (2004) Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 45:1712-1715. doi: 10.1167/iovs.03-1303
8. Vannay A, Dunai G, Banyasz I, Szabo M, Vamos R, Treszl A, Hajdu J, Tulassay T, Vasarhelyi B (2005) Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 57:396-398. doi: 10.1203/ 01.PDR.0000153867.80238.E0
9. Banyasz I, Bokodl G, Vannay A, Szebeni B, Treszl A, Vasarhelyi B, Tulassay T, Szabo A (2006) Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr Eye Res 31:685-690. doi: 10.1080/02713680600801123
10. Dunai G, Vasarhelyi B, Szabo M, Hajdu J, Meszaros G, Tulassay T, Treszl A (2008) Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. Curr Eye Res 33:501-505